BRONJ In A Patient with Rheumatoid Arthritis: An Unnamed
Association
Yusuf Ziya Şener*1 Burak Yasin Aktaş1, Levent Kılıç2, Ahmet Çağkan İnkaya3 and Umut Kalyoncu2
DOI: 10.26717/BJSTR.2017.01.000198
-
Author Information
Open or Close
- 1Department of Internal Medicine, Hacettepe University, Turkey
- 2Department of Rheumatology, Hacettepe University, Turkey
- 3Department of Infectious Diseases, Hacettepe University, Turkey
Corresponding author:
Yusuf Ziya Şener, Faculty of Medicine, Department of Internal Medicine, Hacettepe University, Turkey
Received: July 10, 2017; Published: July 18, 2017
To view the Full Article Peer-reviewed Article PDF
Abstract
Bisphosphonates (BPs) are important drugs in treatment and prevention of all types of osteoporosis. BRONJ is a well known complication of BP treatment since 2002 when it was firstly described. Although most of the reported cases are patients with malignancies. Rheumatoid arthritis is a well known risk factor for BRONJ. In this report, we present a patient with BRONJ who was in our follow up due to rheumatoid arthritis.
Introduction|
Case Report|
Discussion|
Conclusion|
References|
ISSN: 2574 -1241
